Zone I retinopathy of prematurity
- PMID: 11124674
- DOI: 10.1067/mpa.2000.107904
Zone I retinopathy of prematurity
Abstract
Introduction: Patients with zone I retinopathy of prematurity (ROP) have poor outcomes despite treatment. We analyze the clinical characteristics and treatment outcome of patients with zone I disease and compare them with patients with zone II disease.
Methods: Preterm infants weighing less than 1500 g at birth were screened by the authors at age 4 to 6 weeks (group A). Group B was composed of referral patients that had been screened elsewhere. Findings were recorded according to the International Classification of Retinopathy of Prematurity. We classified all patients as either zone I, zone II, or zone III disease. If a retinopathy spanned 2 zones in one eye, it was classified in the most posterior zone as indicated by the International Classification of Retinopathy of Prematurity. Threshold was defined as in the Cryotherapy for Retinopathy of Prematurity study. Indirect diode-laser treatment was used to ablate the avascular retina. At the 3-month follow-up, outcome was judged according to Cryotherapy for Retinopathy of Prematurity criteria. Differences between eyes with zone I or zone II ROP were analyzed.
Results: Group A was composed of 222 infants; 2 presented with zone I ROP. Of 63 patients comprising group B, 9 had zone I ROP: a total of 11 infants with zone I ROP, 22 eyes. At 3 months, 8 of 20 eyes with zone I ROP that were included in follow-up had an unfavorable outcome (40%). Mean birth weight and gestational age were similar in zone I and zone II cases, but mean gestational age at treatment was significantly different (35.2 weeks in zone I cases vs 37.2 weeks in zone II cases, P =.006). Unusual signs such as a demarcation vessel between vascular and avascular retina and excessive intraretinal neovascularization were observed in zone I eyes but not observed in eyes with zone II or zone III ROP.
Discussion: Zone I ROP appears to be different from zone II ROP. Earlier treatment age suggests either an early start, faster progression, or both. Special attention should be given to atypical morphology present in zone I ROP.
Similar articles
-
[Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].Cesk Slov Oftalmol. 2012 Feb;68(1):29-36. Cesk Slov Oftalmol. 2012. PMID: 22679695 Clinical Trial. Czech.
-
The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.Ophthalmology. 2001 Jan;108(1):27-34; discussion 34-5. doi: 10.1016/s0161-6420(00)00436-x. Ophthalmology. 2001. PMID: 11150259
-
Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.Int Ophthalmol. 2011 Feb;31(1):3-8. doi: 10.1007/s10792-010-9411-y. Epub 2010 Dec 31. Int Ophthalmol. 2011. PMID: 21194006 Clinical Trial.
-
Treatment of retinopathy of prematurity.Early Hum Dev. 2008 Feb;84(2):95-9. doi: 10.1016/j.earlhumdev.2007.11.007. Early Hum Dev. 2008. PMID: 18280405 Review.
-
International Classification of Retinopathy of Prematurity, Third Edition.Ophthalmology. 2021 Oct;128(10):e51-e68. doi: 10.1016/j.ophtha.2021.05.031. Epub 2021 Jul 8. Ophthalmology. 2021. PMID: 34247850 Free PMC article. Review.
Cited by
-
Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity.Br J Ophthalmol. 2014 Apr;98(4):507-12. doi: 10.1136/bjophthalmol-2013-304109. Epub 2014 Jan 8. Br J Ophthalmol. 2014. PMID: 24403566 Free PMC article.
-
Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment.Sci Rep. 2017 Sep 19;7(1):11894. doi: 10.1038/s41598-017-12264-z. Sci Rep. 2017. PMID: 28928468 Free PMC article. Clinical Trial.
-
Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.Graefes Arch Clin Exp Ophthalmol. 2011 Sep;249(9):1295-301. doi: 10.1007/s00417-011-1678-9. Epub 2011 Apr 15. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21494873
-
Low-dose ranibizumab administration in retinopathy of prematurity.Int Ophthalmol. 2022 May;42(5):1545-1552. doi: 10.1007/s10792-021-02145-w. Epub 2022 Jan 7. Int Ophthalmol. 2022. PMID: 34993841
-
Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity.Clin Ophthalmol. 2015 Oct 29;9:2027-32. doi: 10.2147/OPTH.S90979. eCollection 2015. Clin Ophthalmol. 2015. PMID: 26604673 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources